Bispecific death receptor agonistic antibodies

Details for Australian Patent Application No. 2010303142 (hide)

Owner Roche Glycart AG

Inventors Bruenker, Peter; Ferrara Koller, Claudia; Grau, Sandra; Herter, Sylvia; Lampert, Christoph; Moessner, Ekkehard; Umana, Pablo; Waldhauer, Inja

Agent Griffith Hack

Pub. Number AU-A-2010303142

PCT Pub. Number WO2011/039126

Priority 09171659.7 29.09.09 EP

Filing date 27 September 2010

Wipo publication date 7 April 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/039126 Priority application(s): WO2011/039126

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010303146-New benzimidazole derivatives and their use as FXR agonists

2010303124-Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives